<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03621878</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-2014-04-321</org_study_id>
    <nct_id>NCT03621878</nct_id>
  </id_info>
  <brief_title>Effect of Neural Mobilization on Lumbosacral Radiculopathy Patients With Peripheral Sensitization</brief_title>
  <official_title>Effect of Neural Mobilization Techniques on Pain, and Hip and Knee Range of Motion on Lumbosacral Radiculopathy Patients With Peripheral Sensitization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mohammed Al-Ghamdi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imam Abdulrahman Bin Faisal University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this study was to investigate the effects of slider and tensioner
      techniques on pain, hip and knee ROM in lumbosacral radiculopathy patients with peripheral
      sensitization. A secondary purpose was to evaluate the correlation between these outcomes
      measurements.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study design: Double-blind case-control trial. Methods: Fifty-one male lumbosacral
      radiculopathy patients with peripheral sensitization, were divided into one of the three
      groups: slider, tensioner, and control. The primary outcome measurements were visual analog
      scale (VAS) for pain, hip range of motion (ROM) during SLR test, and knee flexion ROM during
      slump test. The measurements were taken at baseline, after 1st, 3rd, and 6th session.

      Statistical Analysis: A two-way mixed design analysis of variance (MANOVA) with post-hoc
      (Bonferonni Correction) was used to calculate the differences with Time (baseline,
      1st,3rd,6th sessions) as a within-group factor and Group (control, slider, and tensioner) as
      a between-group factor. The effect size was calculated with Cohen's d. Pearson's correlation
      was used for correlation analysis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2015</start_date>
  <completion_date type="Actual">March 30, 2018</completion_date>
  <primary_completion_date type="Actual">November 28, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Care Provider, Outcomes Assessor)</masking>
    <masking_description>both the examiner and the outcomes assessor where blinded to the participants groups. the primary investigator was also blind to the outcomes of each participant during the study period.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analog Scale</measure>
    <time_frame>The measurements were taken at days &quot;0,1,5,12&quot;</time_frame>
    <description>Visual analog scale was used to measure pain intensity. This scale is a 10 cm line where patients chose from 0 to 10 (when 0 mean no pain and 10 mean maximum pain)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hip Flexion Range of Motion (Symptomatic Side)</measure>
    <time_frame>The measurements were taken at days &quot;0,1,5,12&quot;</time_frame>
    <description>Change in Hip flexion range of motion during straight leg raising (symptomatic side)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee Flexion Range of Motion (Symptomatic Side)</measure>
    <time_frame>The measurements were taken at days &quot;0,1,5,12&quot;</time_frame>
    <description>Change in Knee flexion range of motion during slump (symptomatic side)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hip Flexion Range of Motion (Asymptomatic Side)</measure>
    <time_frame>The measurements were taken at days &quot;0,1,5,12&quot;</time_frame>
    <description>Change in Hip Flexion Range of Motion During Straight Leg Raising (Asymptomatic Side)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee Flexion Range of Motion (Asymptomatic Side)</measure>
    <time_frame>The measurements were taken at days &quot;0,1,5,12&quot;</time_frame>
    <description>Change in Knee flexion range of motion during slump (Asymptomatic side)</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Radiculopathy</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in this group had 6 sessions in 2 weeks of Transcutaneous Electric Nerve Stimulation (TENS).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tensioner Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group had 6 sessions in 2 weeks of TENS combined with neural mobilization exercises (Tensioner technique).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Slider Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group had 6 sessions in 2 weeks of TENS combined with neural mobilization exercises (Slider technique).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neural mobilization exercises -Tensioner technique</intervention_name>
    <description>Exercise aiming to lengthen the neural structure using more than one joint.</description>
    <arm_group_label>Tensioner Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Neural mobilization exercises -Slider technique</intervention_name>
    <description>Exercise aiming to slide/glide the neural structure using more than one joint.</description>
    <arm_group_label>Slider Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Transcutaneous Electrical Nerve Stimulation (TENS)</intervention_name>
    <description>Electrotherapy device aiming to decrease patient's symptoms.</description>
    <arm_group_label>Control group</arm_group_label>
    <other_name>Control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with lumbosacral radiculopathy with dominant peripheral sensitization

          -  patients with unilateral leg pain.

          -  patient S-LANSS score &gt; 12,

          -  negative sensory and motor examination.

          -  positive neural tissue provocation tests (straight leg raising test, slump test).

          -  adult.

          -  pain duration of more than 3 months.

        Exclusion Criteria:

          -  S-LANSS score â‰¥ 12,

          -  motor or sensory deficits,

          -  history of back or lower extremity surgeries,

          -  bilateral referred pain,

          -  patients with pacemakers, cardiovascular problems, epilepsy, active malignancy,
             dermatological conditions, and diminished pain sensation.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>July 30, 2018</study_first_submitted>
  <study_first_submitted_qc>August 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2018</study_first_posted>
  <results_first_submitted>January 23, 2019</results_first_submitted>
  <results_first_submitted_qc>May 20, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">July 22, 2019</results_first_posted>
  <last_update_submitted>May 20, 2019</last_update_submitted>
  <last_update_submitted_qc>May 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 22, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Imam Abdulrahman Bin Faisal University</investigator_affiliation>
    <investigator_full_name>Mohammed Al-Ghamdi</investigator_full_name>
    <investigator_title>Physical Therapist</investigator_title>
  </responsible_party>
  <keyword>Lumbosacral radiculopathy</keyword>
  <keyword>peripheral sensitization</keyword>
  <keyword>Neural mobilization</keyword>
  <keyword>radicular LBP</keyword>
  <keyword>slider</keyword>
  <keyword>tensioner</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Radiculopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 17, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/78/NCT03621878/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Control Group</title>
          <description>patients in this group had 6 session of Transcutaneous Electric Nerve Stimulation in 2 weeks.
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
        </group>
        <group group_id="P2">
          <title>Tensioner Group</title>
          <description>patients in this group had 6 session of TENS combined with Neural mobilization exercises -Tensioner technique in 2 weeks.
Neural mobilization exercises -Tensioner technique: a maneuver was done to increase the tension by lengthening the neural structure
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
        </group>
        <group group_id="P3">
          <title>Slider Group</title>
          <description>patients in this group had 6 session of TENS combined with Neural mobilization exercises -Slider technique in 2 weeks.
Neural mobilization exercises -Slider technique: maneuver that produces a sliding motion between the neural tissues and the surrounding structures
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="17"/>
                <participants group_id="P3" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Control Group</title>
          <description>patients in this group had 6 session of Transcutaneous Electric Nerve Stimulation in 2 weeks.
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
        </group>
        <group group_id="B2">
          <title>Tensioner Group</title>
          <description>patients in this group had 6 session of TENS combined with Neural mobilization exercises -Tensioner technique in 2 weeks.
Neural mobilization exercises -Tensioner technique: a maneuver was done to increase the tension by lengthening the neural structure
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
        </group>
        <group group_id="B3">
          <title>Slider Group</title>
          <description>patients in this group had 6 session of TENS combined with Neural mobilization exercises -Slider technique in 2 weeks.
Neural mobilization exercises -Slider technique: maneuver that produces a sliding motion between the neural tissues and the surrounding structures
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="17"/>
            <count group_id="B2" value="17"/>
            <count group_id="B3" value="17"/>
            <count group_id="B4" value="51"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                    <count group_id="B2" value="17"/>
                    <count group_id="B3" value="17"/>
                    <count group_id="B4" value="51"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="40.24" spread="9.49"/>
                    <measurement group_id="B2" value="33.53" spread="8.64"/>
                    <measurement group_id="B3" value="36.82" spread="8.01"/>
                    <measurement group_id="B4" value="36.86" spread="8.99"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                    <count group_id="B2" value="17"/>
                    <count group_id="B3" value="17"/>
                    <count group_id="B4" value="51"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="17"/>
                    <measurement group_id="B4" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                    <count group_id="B4" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>body mass insex</title>
          <units>Kg/m^2</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                    <count group_id="B2" value="17"/>
                    <count group_id="B3" value="17"/>
                    <count group_id="B4" value="51"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.08" spread="3.83"/>
                    <measurement group_id="B2" value="28.23" spread="6.04"/>
                    <measurement group_id="B3" value="28.19" spread="5.60"/>
                    <measurement group_id="B4" value="27.83" spread="5.16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pain</title>
          <description>visual analog scale was used to measure pain intensity in the baseline measurement. this scale is a 10 cm line where patients chose from 0 to 10 (when 0 mean no pain and 10 mean maximum pain)</description>
          <units>Centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="17"/>
                    <count group_id="B2" value="17"/>
                    <count group_id="B3" value="17"/>
                    <count group_id="B4" value="51"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.63" spread="1.75"/>
                    <measurement group_id="B2" value="5.09" spread="1.95"/>
                    <measurement group_id="B3" value="5.05" spread="2.15"/>
                    <measurement group_id="B4" value="5.26" spread="1.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Analog Scale</title>
        <description>Visual analog scale was used to measure pain intensity. This scale is a 10 cm line where patients chose from 0 to 10 (when 0 mean no pain and 10 mean maximum pain)</description>
        <time_frame>The measurements were taken at days &quot;0,1,5,12&quot;</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>patients in this group had 6 session of Transcutaneous Electric Nerve Stimulation in 2 weeks.
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
          </group>
          <group group_id="O2">
            <title>Slider Group</title>
            <description>patients in this group had 6 session of TENS combined with Neural mobilization exercises -Slider technique in 2 weeks.
Neural mobilization exercises -Slider technique: maneuver that produces a sliding motion between the neural tissues and the surrounding structures
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
          </group>
          <group group_id="O3">
            <title>Tensioner Group</title>
            <description>patients in this group had 6 session of TENS combined with Neural mobilization exercises -Tensioner technique in 2 weeks.
Neural mobilization exercises -Tensioner technique: a maneuver was done to increase the tension by lengthening the neural structure
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Scale</title>
          <description>Visual analog scale was used to measure pain intensity. This scale is a 10 cm line where patients chose from 0 to 10 (when 0 mean no pain and 10 mean maximum pain)</description>
          <units>Centimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Basline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.638" spread="1.75762"/>
                    <measurement group_id="O2" value="5.050" spread="2.15029"/>
                    <measurement group_id="O3" value="5.094" spread="1.95015"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 1st Day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.894" spread="1.86001"/>
                    <measurement group_id="O2" value="4.759" spread="1.99125"/>
                    <measurement group_id="O3" value="3.576" spread="2.22810"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 5th Day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.100" spread="1.87508"/>
                    <measurement group_id="O2" value="3.556" spread="2.21613"/>
                    <measurement group_id="O3" value="2.606" spread="2.02005"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 12th Day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.665" spread="1.74676"/>
                    <measurement group_id="O2" value="2.626" spread="2.23538"/>
                    <measurement group_id="O3" value="2.082" spread="1.56734"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Hip Flexion Range of Motion (Symptomatic Side)</title>
        <description>Change in Hip flexion range of motion during straight leg raising (symptomatic side)</description>
        <time_frame>The measurements were taken at days &quot;0,1,5,12&quot;</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>patients in this group had 6 session of Transcutaneous Electric Nerve Stimulation in 2 weeks.
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
          </group>
          <group group_id="O2">
            <title>Slider Group</title>
            <description>patients in this group had 6 session of TENS combined with Neural mobilization exercises -Slider technique in 2 weeks.
Neural mobilization exercises -Slider technique: maneuver that produces a sliding motion between the neural tissues and the surrounding structures
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
          </group>
          <group group_id="O3">
            <title>Tensioner Group</title>
            <description>patients in this group had 6 session of TENS combined with Neural mobilization exercises -Tensioner technique in 2 weeks.
Neural mobilization exercises -Tensioner technique: a maneuver was done to increase the tension by lengthening the neural structure
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
          </group>
        </group_list>
        <measure>
          <title>Hip Flexion Range of Motion (Symptomatic Side)</title>
          <description>Change in Hip flexion range of motion during straight leg raising (symptomatic side)</description>
          <units>degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51.82" spread="15.314"/>
                    <measurement group_id="O2" value="57.71" spread="16.042"/>
                    <measurement group_id="O3" value="46.29" spread="16.243"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 1st Day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.53" spread="13.884"/>
                    <measurement group_id="O2" value="63.59" spread="15.452"/>
                    <measurement group_id="O3" value="58.88" spread="16.714"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 5th Day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="59.24" spread="14.338"/>
                    <measurement group_id="O2" value="67.47" spread="15.412"/>
                    <measurement group_id="O3" value="62.82" spread="13.956"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 12th Day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="57.71" spread="17.944"/>
                    <measurement group_id="O2" value="74.41" spread="22.327"/>
                    <measurement group_id="O3" value="68.59" spread="12.555"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Knee Flexion Range of Motion (Symptomatic Side)</title>
        <description>Change in Knee flexion range of motion during slump (symptomatic side)</description>
        <time_frame>The measurements were taken at days &quot;0,1,5,12&quot;</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>patients in this group had 6 session of Transcutaneous Electric Nerve Stimulation in 2 weeks.
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
          </group>
          <group group_id="O2">
            <title>Slider Group</title>
            <description>patients in this group had 6 session of TENS combined with Neural mobilization exercises -Slider technique in 2 weeks.
Neural mobilization exercises -Slider technique: maneuver that produces a sliding motion between the neural tissues and the surrounding structures
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
          </group>
          <group group_id="O3">
            <title>Tensioner Group</title>
            <description>patients in this group had 6 session of TENS combined with Neural mobilization exercises -Tensioner technique in 2 weeks.
Neural mobilization exercises -Tensioner technique: a maneuver was done to increase the tension by lengthening the neural structure
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
          </group>
        </group_list>
        <measure>
          <title>Knee Flexion Range of Motion (Symptomatic Side)</title>
          <description>Change in Knee flexion range of motion during slump (symptomatic side)</description>
          <units>degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52.29" spread="17.395"/>
                    <measurement group_id="O2" value="45.647" spread="18.435"/>
                    <measurement group_id="O3" value="47.059" spread="14.545"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 1st Day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="49.41" spread="17.603"/>
                    <measurement group_id="O2" value="31.294" spread="12.133"/>
                    <measurement group_id="O3" value="34.824" spread="15.509"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 5th Day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="48" spread="14.018"/>
                    <measurement group_id="O2" value="31.412" spread="14.590"/>
                    <measurement group_id="O3" value="31.765" spread="14.342"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 12th Day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="47" spread="16.733"/>
                    <measurement group_id="O2" value="26.882" spread="15.419"/>
                    <measurement group_id="O3" value="64.47" spread="25.529"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Hip Flexion Range of Motion (Asymptomatic Side)</title>
        <description>Change in Hip Flexion Range of Motion During Straight Leg Raising (Asymptomatic Side)</description>
        <time_frame>The measurements were taken at days &quot;0,1,5,12&quot;</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>patients in this group had 6 session of Transcutaneous Electric Nerve Stimulation in 2 weeks.
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
          </group>
          <group group_id="O2">
            <title>Slider Group</title>
            <description>patients in this group had 6 session of TENS combined with Neural mobilization exercises -Slider technique in 2 weeks.
Neural mobilization exercises -Slider technique: maneuver that produces a sliding motion between the neural tissues and the surrounding structures
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
          </group>
          <group group_id="O3">
            <title>Tensioner Group</title>
            <description>patients in this group had 6 session of TENS combined with Neural mobilization exercises -Tensioner technique in 2 weeks.
Neural mobilization exercises -Tensioner technique: a maneuver was done to increase the tension by lengthening the neural structure
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
          </group>
        </group_list>
        <measure>
          <title>Hip Flexion Range of Motion (Asymptomatic Side)</title>
          <description>Change in Hip Flexion Range of Motion During Straight Leg Raising (Asymptomatic Side)</description>
          <units>degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.00" spread="15.313"/>
                    <measurement group_id="O2" value="71.824" spread="20.467"/>
                    <measurement group_id="O3" value="63.59" spread="15.407"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 1st Day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="69.41" spread="17.044"/>
                    <measurement group_id="O2" value="70.82" spread="20.944"/>
                    <measurement group_id="O3" value="69.12" spread="13.114"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 5th Day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.12" spread="11.146"/>
                    <measurement group_id="O2" value="74.12" spread="18.721"/>
                    <measurement group_id="O3" value="72.12" spread="11.033"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 12th Day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.06" spread="12.920"/>
                    <measurement group_id="O2" value="74.88" spread="19.251"/>
                    <measurement group_id="O3" value="72.47" spread="10.869"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Knee Flexion Range of Motion (Asymptomatic Side)</title>
        <description>Change in Knee flexion range of motion during slump (Asymptomatic side)</description>
        <time_frame>The measurements were taken at days &quot;0,1,5,12&quot;</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Control Group</title>
            <description>patients in this group had 6 session of Transcutaneous Electric Nerve Stimulation in 2 weeks.
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
          </group>
          <group group_id="O2">
            <title>Slider Group</title>
            <description>patients in this group had 6 session of TENS combined with Neural mobilization exercises -Slider technique in 2 weeks.
Neural mobilization exercises -Slider technique: maneuver that produces a sliding motion between the neural tissues and the surrounding structures
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
          </group>
          <group group_id="O3">
            <title>Tensioner Group</title>
            <description>patients in this group had 6 session of TENS combined with Neural mobilization exercises -Tensioner technique in 2 weeks.
Neural mobilization exercises -Tensioner technique: a maneuver was done to increase the tension by lengthening the neural structure
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
          </group>
        </group_list>
        <measure>
          <title>Knee Flexion Range of Motion (Asymptomatic Side)</title>
          <description>Change in Knee flexion range of motion during slump (Asymptomatic side)</description>
          <units>degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="17"/>
                <count group_id="O2" value="17"/>
                <count group_id="O3" value="17"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="31.1176" spread="19.70052"/>
                    <measurement group_id="O2" value="31.7059" spread="12.01439"/>
                    <measurement group_id="O3" value="28.8824" spread="18.01001"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 1st Day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30.41" spread="22.319"/>
                    <measurement group_id="O2" value="24.06" spread="13.831"/>
                    <measurement group_id="O3" value="26.06" spread="14.528"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 5th Day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.94" spread="18.216"/>
                    <measurement group_id="O2" value="28.76" spread="19.250"/>
                    <measurement group_id="O3" value="23.88" spread="13.453"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>After 12th Day</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24.88" spread="17.517"/>
                    <measurement group_id="O2" value="22.29" spread="16.669"/>
                    <measurement group_id="O3" value="20.35" spread="12.639"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>data was collected in around 3 years</time_frame>
      <desc>no participants was in risk of mortality or Serious Adverse Events because the participants in this study ware patients with mild low back pain and and all the treatment we used ware gentle and without any serious adverse effects.</desc>
      <group_list>
        <group group_id="E1">
          <title>Control Group</title>
          <description>patients in this group had 6 session of Transcutaneous Electric Nerve Stimulation in 2 weeks.
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
        </group>
        <group group_id="E2">
          <title>Tensioner Group</title>
          <description>patients in this group had 6 session of TENS combined with Neural mobilization exercises -Tensioner technique in 2 weeks.
Neural mobilization exercises -Tensioner technique: a maneuver was done to increase the tension by lengthening the neural structure
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
        </group>
        <group group_id="E3">
          <title>Slider Group</title>
          <description>patients in this group had 6 session of TENS combined with Neural mobilization exercises -Slider technique in 2 weeks.
Neural mobilization exercises -Slider technique: maneuver that produces a sliding motion between the neural tissues and the surrounding structures
Transcutaneous Electric Nerve Stimulation: electric current produced by a device to stimulate the nerves for pain management</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="17"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="17"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="17"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Mohammed Alghamdi</name_or_title>
      <organization>imam abdulrahman bin faisal university</organization>
      <phone>+966556852888</phone>
      <email>mohdg.ios@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

